Swissport International's Netherlands subsidiary has gained IATA's CEIV certificate for pharmaceutical logistics at (CEIV Pharma) Amsterdam's Schiphol airport.
CEIV Pharma certification for the ground and air cargo services provider in the Netherlands will increase its contribution to the Pharma Gateway Amsterdam – a programme established in 2016 to position Schiphol as a key European pharma hub.
The company said in a statement: "Swissport Netherlands is developing a dedicated product line for the handling of life science & healthcare shipments. With the recent acquisition of Terminal 9, the scope for this product line was broadened and today, all of Swissport’s operational activities in the Netherlands (both Terminal 9 and 11) are successfully awarded by the IATA CEIV certification."
Jeroen Giling, director cargo at Swissport Netherlands, said: “The certificate is a validation of the hard work that our team put in the pharma product. But that is not where we stop.
"In co-operation with our valued customers, we believe that the pharma product is a product line with continuous improvement cycles. This means that we will keep investing in training our staff, maintaining the best controlled pharma facilities and further develop procedures to ensure a secure and high quality pharma chain.”
Swissport International handles 4.3m tonnes of cargo a year on behalf of some 835 client-companies in the aviation sector.
A number of companies have received CEIV Pharma certification in recent weeks, including Amerijet, Delta and CEVA.
Read more pharma news
